Navigation Links
Frozen Yet Potent Viruses Found

Virus causing flu can survive for decades and longer, in frozen lakes and are very well capable of infecting humans and animals once again.//

Dr Scott Rogers of Bowling Green State University of Ohio and his team have found viral RNA perfectly preserved and still potent in a frozen lake of Siberia. Such frozen viruses can be picked up by migratory birds and are capable of causing outbreaks of viral diseases. Those viruses could even cause new epidemics that could sicken and kill many generations after they were last seen, so report researchers in the Journal of Virology.

Migrating birds are said to be the carriers of avian influenza (bird flu) that has spread into 50 countries and killed around 153 persons.

The virus, which causes avian influenza, H5N1 is a descendant of H1N1 that caused a pandemic in 1918, leaving around 40 to 100 million persons dead. This virus was recovered from the frozen body of a victim in Alaska. Were that strain of H1N1 to circulate today, it could cause another serious pandemic because no one alive now has immunity to it, Rogers said.

Dr. Rogers and his team had also discovered a strain of H1 virus that circulated during the late 1930s and 1960s.

The data taken from the study of Dr. Rogers and his team suggested that influenza A virus deposited as the birds begin their autumn migration could be preserved in lake ice and released as the ice melted. This in turn could be picked up again by migrating birds and spread along their paths of flight.
SRM
'"/>




Page: 1

Related medicine news :

1. Frozen Canadian baby stages miraculous recovery
2. Frozen food invite food poisoning
3. Baby Born Through Frozen Donor Egg
4. Frozen fish is costly and also lacks vital nutrients
5. Frozen embryos stored in Britain
6. Salmonella Poisoned Frozen Pasta Hit Six
7. Brain-Damaged Girl Frozen in Time to Remain Child-Sized Forever
8. Not to Be Frozen
9. Californian Baby Creates History - Born from a Frozen Egg and Sperm
10. Potential New Cancer Gene Identified
11. Lack of Smell And Its Potential Risks
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Frozen Yet Potent Viruses Found

Breaking Medicine News(10 mins):Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 2Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 3Health News:Are manometric findings different between the patients with erosive and nonerosive disease? 2Health News:Custom Health Plans Revamps Web site and Launches Blog to Help Consumers Find the Best Options for Affordable Health Insurance 2Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 2Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 3Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5
Breaking Medicine Technology:Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R) 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 1Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 2Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 3Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 1Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 2Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 3